Literature DB >> 31444266

Influenza vaccination in patients with heart failure: a systematic review and meta-analysis of observational studies.

Bárbara Sucena Rodrigues1, Cláudio David2, João Costa2,3, Joaquim J Ferreira2,3, Fausto J Pinto4,5, Daniel Caldeira6,4,5.   

Abstract

OBJECTIVE: Despite the progression of treatments over decades, heart failure (HF) is a disease with high morbidity, mortality and economic burden. Influenza infection is an important trigger for cardiovascular (CV) events, including HF. Influenza vaccination has been seen to reduce the risk of CV mortality in patients with coronary disease, but the effect in patients with HF is still unclear. Therefore, we conducted a systematic review to evaluate the effect of influenza vaccination in the morbimortality of patients with HF.
METHODS: MEDLINE, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, Health Technology Assessment and PsycINFO databases (December 2018) were searched for longitudinal studies evaluating influenza vaccination compared with a non-vaccination control group in patients with HF. The risk of bias was assessed according to the ROBINS-I tool. We performed a random-effects meta-analysis to estimate the pooled HRs with 95% CIs, and heterogeneity was evaluated using the I2 statistics.
RESULTS: Six cohort studies evaluating 179 158 patients with HF were included in the meta-analysis. Influenza vaccination was associated with a lower risk of all-cause mortality (HR=0.83; 95% CI 0.76 to 0.91; I2=75%). The effect of the influenza vaccination was not statistically significant in a pooled analysis of CV mortality (HR=0.92, 95% CI 0.73 to 1.15; 2 studies) and of all-cause hospitalisations (HR=1.01, 95% CI 0.92 to 1.11; 2 studies). The majority of outcomes in the included studies had a serious risk of bias and almost all evaluated outcomes had very low Grading of Recommendation, Assessment, Development and Evaluation (GRADE) evidence.
CONCLUSIONS: Influenza vaccination was associated with a significant decrease in all-cause mortality risk in patients with HF. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  Coryza; Flu; Influenza; Vaccine; heart failure

Mesh:

Substances:

Year:  2019        PMID: 31444266     DOI: 10.1136/heartjnl-2019-315193

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  11 in total

1.  [Trend analysis of influenza vaccination among hospitalized elderly people in Beijing, 2013-2019].

Authors:  G Q Liu; Y J Pang; J Wu; M Lv; M K Yu; Y T Li; Y M Huang
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2022-06-18

Review 2.  Effects of influenza vaccination on the risk of cardiovascular and respiratory diseases and all-cause mortality.

Authors:  Yangyang Cheng; Xinxi Cao; Zhi Cao; Chenjie Xu; Li Sun; Ying Gao; Yuan Wang; Shu Li; Cunjin Wu; Xin Li; Yaogang Wang; Sean X Leng
Journal:  Ageing Res Rev       Date:  2020-07-16       Impact factor: 10.895

3.  Influenza and Pneumococcal Vaccination in Non-Infected Cardiometabolic Patients from the Americas during the COVID-19 Pandemic. A Sub-Analysis of the CorCOVID-LATAM Study.

Authors:  Álvaro Sosa Liprandi; Ezequiel José Zaidel; Ricardo Lopez Santi; John Jairo Araujo; Manuel Alfonso Baños González; Juan Martín Busso; Luz Cabral; Jorge Camilletti; Juan Erriest; Roberto Flores; Ezequiel Forte; Mirecly Guzman Ramos; Máxima Mendez Castillo; Leonardo Josué Ramírez Zambrano; Carmen Roa; Piero Custodio-Sanchez; Gustavo Solache Ortiz; Bernardo Spitz; Adrián Baranchuk
Journal:  Vaccines (Basel)       Date:  2021-02-04

4.  Self-care of heart failure patients: practical management recommendations from the Heart Failure Association of the European Society of Cardiology.

Authors:  Tiny Jaarsma; Loreena Hill; Antoni Bayes-Genis; Hans-Peter Brunner La Rocca; Teresa Castiello; Jelena Čelutkienė; Elena Marques-Sule; Carla M Plymen; Susan E Piper; Barbara Riegel; Frans H Rutten; Tuvia Ben Gal; Johann Bauersachs; Andrew J S Coats; Ovidiu Chioncel; Yuri Lopatin; Lars H Lund; Mitja Lainscak; Brenda Moura; Wilfried Mullens; Massimo F Piepoli; Giuseppe Rosano; Petar Seferovic; Anna Strömberg
Journal:  Eur J Heart Fail       Date:  2020-10-20       Impact factor: 15.534

Review 5.  Influenza Neuraminidase Characteristics and Potential as a Vaccine Target.

Authors:  Sarah Creytens; Mirte N Pascha; Marlies Ballegeer; Xavier Saelens; Cornelis A M de Haan
Journal:  Front Immunol       Date:  2021-11-16       Impact factor: 7.561

6.  Low risk of haematomas with intramuscular vaccines in anticoagulated patients: a systematic review with meta-analysis.

Authors:  Daniel Caldeira; Bárbara Sucena Rodrigues; Mariana Alves; Fausto J Pinto; Joaquim J Ferreira
Journal:  Thromb J       Date:  2022-02-16

Review 7.  Impact of COVID-19 on the Cardiovascular System: A Review.

Authors:  Kensuke Matsushita; Benjamin Marchandot; Laurence Jesel; Patrick Ohlmann; Olivier Morel
Journal:  J Clin Med       Date:  2020-05-09       Impact factor: 4.241

Review 8.  The role of angiotensin-converting enzyme 2 in coronaviruses/influenza viruses and cardiovascular disease.

Authors:  Li Chen; Guang Hao
Journal:  Cardiovasc Res       Date:  2020-10-01       Impact factor: 10.787

9.  Decline in respiratory and cardiac admissions during the COVID-19 pandemic: What is the role of common respiratory virus infections?

Authors:  Chloe I Bloom; Sebastian L Johnston
Journal:  Respirology       Date:  2021-08-23       Impact factor: 6.424

10.  Impact of COVID-19 pandemic restrictions on the cardio-respiratory health of New Zealanders.

Authors:  Sarah M Fairweather; Catherina L Chang; Christopher J Mansell; Eskandarain Shafuddin; Robert J Hancox
Journal:  Respirology       Date:  2021-08-08       Impact factor: 6.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.